LAJU FILTRASI GLOMERULUS PASIEN DIABETES MELITUS TIPE II DI SALAH SATU RUMAH SAKIT SWASTA DI KABUPATEN DEMAK
DOI:
https://doi.org/10.33759/jrki.v3i3.179Keywords:
Glomerulus Filtration Rate, JKN Participants, DM Type IIAbstract
Diabetes Mellitus (DM) Type II is a group of metabolic diseases with hyperglycemia characteristics. The use of oral hypoglycemic drugs (OHO) lasts for a relatively long time. Most of the OHO is excreted through the kidneys. This study aims to determine the Glomerulus Filtration Rate (GFR) of type 2 DM patients who use OHO at the "X" Hospital, District of Demak. This study is an observational descriptive study using retrospective data obtained from medical record data (RM) of outpatient JKN participants with type 2 DM for the period October-December 2020. Inclusion criteria were patients who received OHO for at least one year with or without comorbidities, aged 36-65 years, and had a serum creatinine test. Patients receiving combination therapy with insulin were excluded. LFG is calculated using the Cockroft-Gault formula. From 82 patients, 52 patients (62.2%) were female, 74 patients (90.2%) were more than 45 years old. Patients who consumed OHO for more than 2 years were 47 (57.3%). Patients without comorbidities were 62 (75.7%) people. Patients who experienced a decrease in GFR in the moderate category (stage 3) as many as 24 people (29.3%), a decrease in GFR in the severe category (stage 4) as many as 5 people (6.1%) and 1 person (1.2%) experienced End Stage Renal Disease.
Downloads
References
American Diabetic Association. (2015). Standard of Medical Care in Diabetes. Diabetic Medicine, 24, 451-463.
Botev, R., Mallie, J. P., Wetzels, J. F. M., Couchoud, C., & Schück, O. (2011). The clinician and estimation of glomerular filtration rate by creatinine-based formulas: Current limitations and Quo vadis. Clinical Journal of the American Society of Nephrology. 6(4):937-950. https://doi.org/10.2215/CJN.09241010
Kee, J. le F. (2014). Pedoman pemeriksaan laboratorium & diagnostic. In EGC. Jakarta.
Kemenkes RI. (2018). Hasil Utama Riskesdas Tentang Prevalensi Diabetes Mellitus di Indonesia 2018.
Marathe, P. H., Gao, H. X., & Close, K. L. (2017). American Diabetes Association Standards of Medical Care in Diabetes 2017. In Journal of diabetes, 9, 320-324. https://doi.org/10.1111/1753-0407.12524
Mildawati, Mildawati., Diani, Noor., Wahid, Abdurrahman. Hubungan Usia, Jenis Kelamin dan Lama Menderita Diabetes dengan Kejadian Neuropati Perifer Diabetik. CNJ: Caring Nursing Journal, [S.l.], 3 (2), 30-37, https://journal.umbjm.ac.id/index.php/caring-nursing/article/view/238
Nanda, O. D., Wiryanto, B., & Triyono, E. A. (2018). Hubungan Kepatuhan Minum Obat Anti Diabetik dengan Regulasi Kadar Gula Darah pada Pasien Perempuan Diabetes Mellitus. Amerta Nutrition. 340-348. https://doi.org/10.20473/amnt.v2i4.2018.340-348
Oktaviani, Emy., Wahyono, Djoko., Probosusesno. (2017). Evaluasi Penggunaan Antidiabetik Oral Pada Pasien DM Tipe 2 dengan Gangguan Fungsi Ginjal Rawat Jalan di RSUP dr.Sardjito Yogyakarta, Rapat Pleno APTFI dan Seminar Nasional. https://repository.unpak.ac.id/tukangna/repo/file/files-20180630170228.pdf
Pandanwangi, S., Zuniarto, A. A., & Mubarok, H. (2018). Analisa Drug Related Problems (DRPS) Pasien Gagal Ginjal Dengan Komplikasi Diabetes Mellitus Di RSUD X. Pharma Xplore : Jurnal Ilmiah Farmasi., 3 (1). https://doi.org/10.36805/farmasi.v3i1.330
Rivandi, J., & Yonata, A. (2015). Hubungan Diabetes Melitus Dengan Kejadian Gagal Ginjal Kronik. Jurnal Majority, 4(9), 27-34.
Shargel, L., Susanna, W.P., Andrew, B.C.Y. (2012). Biofarmasetika dan Farmakokinetika Terapan, Ed. Kelima, Pusat Penerbitan dan Percetakan Universitas Airlangga Surabaya.
Verdiansyah. (2016). Pemeriksaan Fungsi Ginjal. CDK : Cermin Dunia Kedokteran, 43 (2) : 148-154.
